• Print

2012 Taubman Prize

For Excellence in Translational Medical Science

This award is presented annually by the A. Alfred Taubman Medical Research Institute at the University of Michigan. It is meant to recognize work in the crucial field of translational research being conducted by the clinician-scientist who has done the most to transform laboratory discoveries into clinical applications for patients suffering from disease.

Prize: $100,000

Eligibility:

  • International scientists are eligible.
  • U-M scientists are excluded.
  • Self-nomination is permitted.

Judging Criteria:

  • Significant contribution to translating basic research findings into medical practice
  • The manner in which nominee’s clinical activities connects to his or her laboratory research
  • Deadline: April 1, 2012

Announcement of Winner:

  • At the annual Taubman Institute Symposium in October 2012. The winner will be asked to serve as the keynote speaker at that event.

Nomination Form

  or Reset
 

Nomination Guidelines

For a nomination to be considered by the selection committee, the following items must be submitted with the completed nomination form:

  • A letter of nomination detailing the individual’s extraordinary or sustained contribution to…
  • The curriculum vitae of the nominee
  • A bibliography of significant publications
  • Two additional letters of support

Electronic submissions are encouraged. Incomplete nominations will not be presented to the nomination committee. The deadline for receiving nominations is April 1, 2012.

If you have any questions, please email This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

 

Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Four Taubman Scholars to share in $3.5 million diabetes grant

Kidney damage, loss of vision and mobility-limiting nerve damage are among the most dreaded side effects of diabetes, an illness affecting nearly 26 million adults and children in the United States.

Read more

New Rayner Fund gives $1 million boost to ALS research

Taubman Institute director Eva Feldman, M.D., Ph.D., and three other Taubman Scholars are among the U-M researchers to share in a $3.5 million grant to study the complications of diabetes.

Read more

Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Advisory Board

Collaboration outside the laboratory

tab1

In addition to supporting scientists and their research, the Taubman Institute has developed programs to foster collaboration outside the laboratory.  Taubman Talks and our new Visiting Professor lecture series are two ways we share the latest in scientific discoveries with colleagues, the campus and the community.

Taubman Talks

One of the cornerstones of the Taubman Institute is a collaborative environment, where the exchange of ideas and creative interaction across disciplines are vigorously promoted.

Learn more

Visiting Professor Lecture Series

The Taubman Institute inaugurated a monthly Visiting Professors series Wednesday, Sept. 21, with a presentation by noted Alzheimer’s expert, Dr. Gary Landreth...

Learn more

 

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

Watch the Video